Regulation Of Ischemic Preconditioning By Compartmentalized Signal Transduction
Regulation Of Ischemic Preconditioning By Compartmentalized Signal Transduction
批准号:
8266384
负责人:
John P O'Bryan
金额:
$27.2万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-14 至 2014-05-31
关键词:
1-Phosphatidylinositol 3-KinaseAKT Signaling PathwayAcute myocardial infarctionAddressBasic ScienceBinding ProteinsBiomedical ResearchBrainCardiacCardiac MyocytesCardiovascular DiseasesCell SurvivalCellsCessation of lifeChronicComplexCoronary heart diseaseCoupledDataDiseaseEndocytosis PathwayExperimental ModelsFamilyFamily memberG-Protein-Coupled ReceptorsGoalsHealthHealthcare SystemsHeartHeart DiseasesInjuryInterventionIschemiaIschemic PreconditioningKnock-outKnockout MiceLinkMediatingMediator of activation proteinModelingMolecularMorbidity - disease rateMusMyocardialMyocardial InfarctionMyocardial IschemiaMyocardiumNational Heart, Lung, and Blood InstituteOxygenPathway interactionsPatientsPhospholipidsPhysiologicalProductionProtein FamilyProtein IsoformsProto-Oncogene Proteins c-aktReceptor Protein-Tyrosine KinasesRegulationReperfusion InjuryReperfusion TherapyRoleScaffolding ProteinSignal PathwaySignal TransductionSocietiesStrategic PlanningStrokeTestingTissuesTransgenic MiceTransgenic ModelTransgenic OrganismsUnited StatesVesiclebasedeprivationeffective therapyexperienceextracellularin vitro Modelin vivoinsightintersectin 1mortalitymouse modelnovelnovel therapeuticsoverexpressionpreconditioningresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Heart disease represents a leading cause of morbidity and mortality in the US. Understanding the causes and developing treatments for this disease is an important goal of biomedical research. Although oxygen deprivation results in damage to cardiac tissue, it is possible to protect the myocardium by brief periods of ischemia-reperfusion. Although this phenomenon involves activation of the phosphatidylinositol-3' kinase pathway (PI3K), the molecular regulation of PI3Ks during this response has not been well defined. In this proposal, we wish to determine the role of the intersectin (ITSN) scaffold protein in regulating the response of cardiac tissue to ischemia-reperfusion (IR) injury through regulation of the PI3K family. We have identified PI3Ks as ITSN-binding proteins and will determine the role of ITSN in regulating PI3Ks both in myocardial cells and in novel mouse models including a cardiac-specific ITSN transgenic mouse (MHC-ITSN) and an ITSN knockout mouse. We propose the following four specific aims to define the molecular mechanisms by which ITSN regulates cardioprotection from ischemic injury: (1) determine the role of ITSN in regulating PI3K activation in cardiomyocytes; (2) determine the mechanism by which ITSN regulates PI3K activation; (3) determine the downstream signals emanating from ITSN-PI3K; and (4) determine the importance of ITSN in mediating cardioprotection in response to IR injury in vivo. The experiments proposed for Specific Aims 1-3 will define the molecular regulation of the various PI3K family members by ITSN in response to G-protein coupled receptor and receptor tyrosine kinase activation and the downstream signals resulting from this activation in in vitro models. In Specific Aim 4, these results will be applied to the study of the novel mouse models created by us. The MHC-ITSN mice will address the consequence of ITSN overexpression on cardioprotection from IR injury whereas the knockout mice will address the consequences of ITSN loss on the response to IR injury. These data will provide novel molecular insight into the regulation of the PI3K family of proteins by ITSN in cardiac tissue and will define the importance of this regulation in cardioprotection and cardiac function. PUBLIC HEALTH RELEVANCE: Myocardial infarction results in a significant burden to the US healthcare system. Our proposed studies will define novel molecular pathways involved in protecting the heart from ischemic injury. Given that these pathways are also shared among many tissues including the brain, these studies may also provide novel insights into limiting the harmful effects from stroke.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1126/scisignal.3152re10
发表时间:
2010-12-14
期刊:
Science signaling
影响因子:
7.3
作者:
[O'Bryan JP]
通讯作者:
O'Bryan JP
DOI:
10.1371/journal.pone.0045360
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Wong KA, Russo A, Wang X, Chen YJ, Lavie A, O'Bryan JP]
通讯作者:
O'Bryan JP
DOI:
10.1371/journal.pone.0030129
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Elsherif L, Wang X, Grachoff M, Wolska BM, Geenen DL, O'Bryan JP]
通讯作者:
O'Bryan JP
DOI:
10.1038/onc.2011.643
发表时间:
2012-11-15
期刊:
ONCOGENE
影响因子:
8
作者:
[Russo, A., O'Bryan, J. P.]
通讯作者:
O'Bryan, J. P.
Development of novel Ras inhibitory agents for cancer therapy"
-
批准号:9213585
-
项目类别:
-
资助金额:$3.14万
-
财政年份:2015
-
负责人:John P O'Bryan
-
依托单位:
Development of novel RAS inhibitory agents for cancer therapy
-
批准号:9188050
-
项目类别:
-
资助金额:$17.32万
-
财政年份:2015
-
负责人:John P O'Bryan
-
依托单位:
Development of novel RAS inhibitory agents for cancer therapy
-
批准号:9379114
-
项目类别:
-
资助金额:$6.63万
-
财政年份:2015
-
负责人:John P O'Bryan
-
依托单位:
Novel Functions for Ras family GTPases
-
批准号:10396030
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:John P O'Bryan
-
依托单位:
Novel Functions for Ras Family GTPases
-
批准号:8633835
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:John P O'Bryan
-
依托单位:
Novel Functions for Ras family GTPases
-
批准号:10620137
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:John P O'Bryan
-
依托单位:
Novel Functions for Ras family GTPases
-
批准号:10249403
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:John P O'Bryan
-
依托单位:
Novel Functions for Ras family GTPases
-
批准号:9240249
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:John P O'Bryan
-
依托单位:
Regulation Of Ischemic Preconditioning By Compartmentalized Signal Transduction
-
批准号:8110093
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2009
-
负责人:John P O'Bryan
-
依托单位:
Regulation Of Ischemic Preconditioning By Compartmentalized Signal Transduction
-
批准号:7737536
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2009
-
负责人:John P O'Bryan
-
依托单位:
Regulation Of Ischemic Preconditioning By Compartmentalized Signal Transduction
-
批准号:7914216
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2009
-
负责人:John P O'Bryan
-
依托单位:
Cath B and uPAR si RNA constructs regressed glioma growth
-
批准号:8444332
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2005
-
负责人:John P O'Bryan
-
依托单位:
Cath B and uPAR si RNA constructs regressed glioma growth
-
批准号:8607140
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2005
-
负责人:John P O'Bryan
-
依托单位:
SHC FAMILY PROTEINS
-
批准号:2465349
-
项目类别:
-
资助金额:$6.2万
-
财政年份:1997
-
负责人:John P O'Bryan
-
依托单位:
BIOLOGIC CHARACTERIZATION OF A NOVEL SHC-LIKE GENE
-
批准号:2112752
-
项目类别:
-
资助金额:$3.12万
-
财政年份:1996
-
负责人:John P O'Bryan
-
依托单位:
BIOLOGIC CHARACTERIZATION OF A NOVEL SHC-LIKE GENE
-
批准号:2112751
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1995
-
负责人:John P O'Bryan
-
依托单位:
Shcc Function In Growth, Development And Cancer
-
批准号:6542238
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:John P O'Bryan
-
依托单位:
Role Of Intersectin Adaptor Protein In Regulation Of End
-
批准号:6673267
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:John P O'Bryan
-
依托单位:
Role Of Intersectin Adaptor Protein In Regulation Of End
-
批准号:6542241
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:John P O'Bryan
-
依托单位:
Intersectin Adaptor Protein In Regulation Of Endocytosis
-
批准号:7007494
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:John P O'Bryan
-
依托单位:
海外基金